Al-Saikhan Fahad I, Abd-Elaziz Mohamed A, Ashour Rehab H
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Department of Clinical Pharmacology, Mansoura Faculty of Medicine, Mansoura University, Mansoura, Al-Dakahlia 35516, Egypt.
Biomed Rep. 2017 Jul;7(1):56-60. doi: 10.3892/br.2017.920. Epub 2017 Jun 1.
The link between the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism and the prevalence of type 2 diabetes mellitus (T2DM) developing in the Saudi Arabian population remains controversial. The aim of the present study was to evaluate the association between the ACE I/D gene polymorphism and the risk of developing T2DM and hypertension (HTN) in Saudi Arabian individuals. A total of 220 individuals consisting of 48 control subjects, 70 T2DM, 48 HTN, and 54 T2DM with HTN patients were recruited. Genotyping was performed by polymerase chain reaction initially and mistyping of the DD genotypes was conducted with an insertion-specific primer. The genotyping frequency for the II, ID and DD polymorphism of the ACE gene was 6.8, 42.6 and 48.6% in T2DM patients, 4.2, 50 and 45.8% in HTN patients, 5.6, 55.5 and 38.9% in T2DM patients with HTN and 58.3, 37.5 and 4.2% in control subjects, respectively. The frequency for the D allele was 70% in T2DM patients, 70.8% in HTN patients and 66.7% in T2DM patients with HTN as compared with 22.9% in the control subjects. The genotype and allele frequency of the ACE gene polymorphism varied significantly (P<0.05) in the patients when compared with the control subjects. The current study demonstrated that the ID/DD genotype and the D allele of the ACE gene I/D polymorphism were strongly associated with the risk of T2DM and HTN developing in a Saudi Arabian population.
血管紧张素转换酶(ACE)插入/缺失(I/D)基因多态性与沙特阿拉伯人群中2型糖尿病(T2DM)的患病率之间的联系仍存在争议。本研究的目的是评估沙特阿拉伯个体中ACE I/D基因多态性与发生T2DM和高血压(HTN)风险之间的关联。共招募了220名个体,包括48名对照受试者、70名T2DM患者、48名HTN患者和54名合并HTN的T2DM患者。最初通过聚合酶链反应进行基因分型,并使用插入特异性引物对DD基因型进行误分型。ACE基因II、ID和DD多态性的基因分型频率在T2DM患者中分别为6.8%、42.6%和48.6%,在HTN患者中分别为4.2%、50%和45.8%,在合并HTN的T2DM患者中分别为5.6%、55.5%和38.9%,在对照受试者中分别为58.3%、37.5%和4.2%。与对照受试者中的22.9%相比,T2DM患者中D等位基因的频率为70%,HTN患者中为70.8%,合并HTN的T2DM患者中为66.7%。与对照受试者相比,患者中ACE基因多态性的基因型和等位基因频率有显著差异(P<0.05)。当前研究表明,ACE基因I/D多态性的ID/DD基因型和D等位基因与沙特阿拉伯人群中发生T2DM和HTN的风险密切相关。